Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies
Clinical trial NCT02160951 · COMPLETED
Trial details
- NCT number
- NCT02160951
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-05-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.